Growing community of inventors

Heidelberg, Germany

Samuel Weisbrod

Average Co-Inventor Count = 4.88

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Samuel WeisbrodNicola Bisek (6 patents)Samuel WeisbrodHarald Rau (5 patents)Samuel WeisbrodSebastian Stark (4 patents)Samuel WeisbrodBurkhardt Laufer (3 patents)Samuel WeisbrodKennett Sprogøe (1 patent)Samuel WeisbrodTorben Lessmann (8 patents)Samuel WeisbrodThomas Knappe (4 patents)Samuel WeisbrodTobias Voigt (3 patents)Samuel WeisbrodRomy Reimann (2 patents)Samuel WeisbrodDavid B Rosen (2 patents)Samuel WeisbrodKornelia Bigott (1 patent)Samuel WeisbrodYang Yang-malten (0 patent)Samuel WeisbrodLars Holten-andersen (0 patent)Samuel WeisbrodHarald Rau (0 patent)Samuel WeisbrodKennett SprogØe (0 patent)Samuel WeisbrodLuis Zuniga (0 patent)Samuel WeisbrodSamuel Weisbrod (6 patents)Nicola BisekNicola Bisek (10 patents)Harald RauHarald Rau (56 patents)Sebastian StarkSebastian Stark (7 patents)Burkhardt LauferBurkhardt Laufer (5 patents)Kennett SprogøeKennett Sprogøe (28 patents)Torben LessmannTorben Lessmann (8 patents)Thomas KnappeThomas Knappe (7 patents)Tobias VoigtTobias Voigt (7 patents)Romy ReimannRomy Reimann (3 patents)David B RosenDavid B Rosen (2 patents)Kornelia BigottKornelia Bigott (1 patent)Yang Yang-maltenYang Yang-malten (0 patent)Lars Holten-andersenLars Holten-andersen (0 patent)Harald RauHarald Rau (0 patent)Kennett SprogØeKennett SprogØe (0 patent)Luis ZunigaLuis Zuniga (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ascendis Pharma A/s (5 from 44 patents)

2. Ascendis Pharma Inc. (1 from 4 patents)

3. Ascendis Pharma Ophthalmology Division A/s (1 from 1 patent)

4. Ascendis Pharma Oncology Division A/s (2 patents)


6 patents:

1. 12246070 - Hydrogel cross-linked hyaluronic acid prodrug compositions and methods

2. 11896671 - Conjugation method for carrier-linked prodrugs

3. 11642415 - Hydrogel cross-linked hyaluronic acid prodrug compositions and methods

4. 11298427 - Prodrugs comprising a pyroglutamate linker

5. 10519226 - VEGF neutralizing prodrugs for the treatment of ocular conditions

6. 10040850 - Protecting group comprising a purification tag

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…